4//SEC Filing
Buck Jill 4
Accession 0001209191-21-003245
CIK 0001107421other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 4:35 PM ET
Size
5.5 KB
Accession
0001209191-21-003245
Insider Transaction Report
Form 4
Buck Jill
EVP, GM Gene Therapy
Transactions
- Sale
Common Stock
2021-01-08$3.12/sh−27,894$87,029→ 199,516 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to satisfy withholding tax obligations upon the vesting of restricted stock grants.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.035 to $3.205, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
ZIOPHARM ONCOLOGY INC
CIK 0001107421
Entity typeother
Related Parties
1- filerCIK 0001780426
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 4:35 PM ET
- Size
- 5.5 KB